Trends in mortality from myocardial infarction. A comparative study between spain and the United States: 1990-2006;Tendencias en mortalidad por infarto de miocardio. Estudio comparativo entre España y Estados Unidos: 1990-2006

Revista Espanola de Cardiologia

Volumn 65, Issue 12, 2012, Pages 1079-1085

  Orozco Beltran, Domingo ^a   Cooper, Richard S ^b   Gil Guillen, Vicente ^a   Bertomeu Martinez, Vicente ^c   Pita Fernandez, Salvador ^d   Durazo Arvizu, Ramón ^b   Carratala Munuera, Concepción ^a   Cea Calvo, Luis ^a   Bertomeu Gonzalez, Vicente ^c   Seoane Pillado, Teresa ^c   Rosado, Luis E ^e  

^a MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

^c HOSPITAL UNIVERSITARIO DE SAN JUAN   (Spain)

^d HOSPITAL JUAN CANALEJO   (Spain)

^e Departamento de Sanidad   (Spain)

Author keywords

Coronary artery disease; Mortality; Myocardial infarction

Indexed keywords

ARTICLE; COMPARATIVE STUDY; DATA BASE; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; RETROSPECTIVE STUDY; SPAIN; UNITED STATES;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK FACTORS; SEX FACTORS; SPAIN; UNITED STATES;

EID: 84869495040     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/j.recesp.2012.02.026     Document Type: Article

References (35)

1. R. Cooper, J. Cutler, P. Desvigne-Nickens, S.P. Fortmann, L. Friedman, and R. Havlik Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention Circulation 102 2000 3137 3147
2. W.D. Rosamond, L.E. Chambless, A.R. Folsom, L.S. Cooper, D.E. Conwill, and L. Clegg Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994 N Engl J Med 339 1998 861 867
3. A. Ergin, P. Muntner, R. Sherwin, and J. He Secular trends in cardiovascular disease mortality, incidence, and case fatality rates in adults in the United States Am J Med 117 2004 219 227
4. S.R. Preis, S.J. Hwang, S. Coady, M.J. Pencina, R.B. D'Agostino Sr., and P.J. Savage Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005 Circulation 119 2009 1728 1735
5. F. Levi, F. Lucchini, E. Negri, and C. La Vecchia Trends in mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world Heart 88 2002 119 124
6. I. Graham, D. Atar, K. Borch-Johnsen, G. Boysen, G. Burell, R. Cifkova European Society of Cardiology (ESC) Committee for Practice Guidelines (CPG) European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts) Eur Heart J 28 2007 2375 2414
7. I. Graham, D. Atar, K. Borch-Johnsen, G. Boysen, G. Burell, and R. Cifkova Guías de práctica clínica sobre prevención de la enfermedad cardiovascular. Versión corregida 22/07/2009 Rev Esp Cardiol 61 2008 82.e1 82.e49
8. National Cancer Institute, Joinpoint Regression Program [Software], Versión 3.4.2. Statistical Research and Applications, National Cancer Institute, October 2009 [citado 18 Mar 2011]. Disponible en: http://srab.cancer.gov/joinpoint
9. F. Levi, L. Chatenoud, P. Bertuccio, F. Lucchini, E. Negri, and C. La Vecchia Mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world: an update Eur J Cardiovasc Prev Rehabil 16 2009 333 350
10. E.S. Ford, U.A. Ajani, J.B. Croft, J.A. Critchley, D.R. Labarthe, and T.E. Kottke Explaining the decrease in U.S. deaths from coronary disease, 1980-2000 N Engl J Med 356 2007 2388 2398
11. L. Goldman, and E.F. Cook The decline in ischemic heart disease mortality rates: an analysis of the comparative effects of medical interventions and changes in lifestyle Ann Intern Med 101 1984 825 836
12. E. Vartiainen, P. Puska, J. Pekkanen, J. Tuomilehto, and P. Jousilahti Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland BMJ 309 1994 23 27
13. M.L. Bots, and D.E. Grobbee Decline of coronary heart disease mortality in the Netherlands from 1978 to 1985: contribution of medical care and changes over time in presence of major cardiovascular risk factors J Cardiovasc Risk 3 1996 271 276
14. S. Capewell, C.E. Morrison, and J.J. McMurray Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994 Heart 81 1999 380 386
15. B. Unal, J.A. Critchley, and S. Capewell Explaining the decline in coronary heart disease mortality in England and Wales, 1981-2000 Circulation 109 2004 1101 1107
16. M. Ezzati, A.D. López, A. Rodgers, S. Vander Hoorn, C.J. Murray Comparative Risk Assessment Collaborating Group Selected major risk factors and global and regional burden of disease Lancet 360 2002 1347 1360
17. S. Lewington, R. Clarke, N. Qizilbash, R. Peto, R. Collins Prospective Studies Collaboration Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies Lancet 360 2002 1903 1913 Fe de erratas en: Lancet. 2003;361:1060
18. K. Wolf-Maier, R.S. Cooper, H. Kramer, J.R. Banegas, S. Giampaoli, and M.R. Joffres Hypertension treatment and control in five European countries, Canada, and the United States Hypertension 43 2004 10 17
19. J.L. Llisterri Caro, G.C. Rodríguez Roca, F.J. Alonso Moreno, J.R. Banegas Banegas, D. González-Segura Alsina, S. Lou Arnal Grupo de Trabajo de Hipertensión Arterial de la Sociedad Española de Atención Primaria (Grupo HTA/SEMERGEN); investigadores del Estudio PRESCAP 2006 Control of blood pressure in Spanish hypertensive population attended in primary health-care. PRESCAP 2006 Study Med Clin (Barc) 130 2008 681 687
20. J. Redón, L. Cea-Calvo, J.V. Lozano, J.C. Martí-Canales, J.L. Llisterri, J. Aznar Investigators of the PREV-ICTUS study Blood Pressure and Estimated Risk of Stroke in the Elderly Population of Spain: The PREV-ICTUS Study Stroke 38 2007 1167 1173
21. C. Baigent, A. Keech, P.M. Kearney, L. Blackwell, G. Buck, C. Pollicino Cholesterol Treatment Trialists' (CTT) Collaborators Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins Lancet 366 2005 1267 1278 Fe de erratas en: Lancet. 2005;366:1358
22. J.J. Brugts, T. Yetgin, S.E. Hoeks, A.M. Gotto, J. Shepherd, and R.G. Westendorp The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials BMJ 338 2009 b2376
23. D.D. Waters, C. Brotons, C.W. Chiang, J. Ferrières, J. Foody, J.W. Jukema Lipid Treatment Assessment Project 2 Investigators Lipid treatment assessment project 2: a multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals Circulation 120 2009 28 34
24. M.H. Davidson, K.C. Maki, T.A. Pearson, R.C. Pasternak, P.C. Deedwania, and J.M. McKenney Results of the National Cholesterol Education (NCEP) Program Evaluation Project Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations Am J Cardiol 96 2005 556 563
25. G. Fores-Mateo, M. Grau, M. O'Flaherty, R. Ramos, R. Elosua, and C. Violan-Fors Análisis de la disminución de la mortalidad por enfermedad coronaria en una población mediterránea: España 1988-2005 Rev Esp Cardiol 64 2011 988 996
26. World Health Organization. World Health Statistics 2010 [citado 18 Mar 2011]. Disponible en: http://www.who.int/whosis/whostat/EN-WHS10-Full.pdf
27. Ley 28/2005, de 26 de diciembre, de medidas sanitarias frente al tabaquismo y reguladora de la venta, el suministro, el consumo y la publicidad de los productos del tabaco. BOE 309 de 27/12/2005 Sec 1. p. 42241-50.
28. Encuestas Nacionales de Salud de España de años anteriores. Disponible en: http://www.msc.es/estadEstudios/estadisticas/encuesta-Nacional/ aniosAnteriores.htm
29. Centers for Disease Control and Prevention. Department of Health and Human Services Percentage of Civilian, Noninstitutionalized Population with Diagnosed Diabetes, by Age, United States, 1980-2006 [citado 21 Mar 2011]. Disponible en: http://www.cdc.gov/Diabetes/statistics/prev/national/figbyage.htm
30. M. Grau, R. Elosua, A. Cabrera de León, M.J. Guembe, J.M. Baena-Díez, and T. Vega Alonso Factores de riesgo cardiovascular en España en la primera década del siglo xxi: análisis agrupado con datos individuales de 11 estudios de base poblacional, estudio DARIOS Rev Esp Cardiol 64 2011 295 304
31. L. Cea-Calvo, B. Moreno, S. Monereo, V. Gil-Guillén, J.V. Lozano, J.C. Martí-Canales PREV-ICTUS Study Prevalence and related factors of overweight and obesity in Spanish population aged 60 years-old or older. The PREV-ICTUS study Med Clin (Barc) 13 2008 205 210
32. World Health Organization. World Health Organization 2008 Report. Global Strategy on Diet, Physical Activity and Health. Obesity and Overweight [citado 18 Mar 2011]. Disponible en: http://www.who.int/dietphysicalactivity/media/en/ gsfs-obesity.pdf
33. C. García-García, G. Sanz, V. Valle, L. Molina, J. Sala, and I. Subirana Evolución de la mortalidad intrahospitalaria y el pronóstico a seis meses de los pacientes con un primer infarto agudo de miocardio. Cambios en la última década Rev Esp Cardiol 63 2010 1136 1144
34. S. Capewell, E.S. Ford, J.B. Croft, J.A. Critchley, K.J. Greenlund, and D.R. Labarthe Cardiovascular trends and potential for reducing coronary heart disease mortality in the United States of America Vull World Health Organ 88 2010 120 130
35. S. Capewell, and M. O'Flaherty Rapid mortality falls after risk-factor changes in populations Lancet 378 2011 752 753